Cronos Group (CRON) – Management Comments
-
Cronos Group (CRON), Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG
-
Cronos Group (CRON) Reports Q1 Loss of $0.44
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CRON Stock Lookup